Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials

Given the urgent need for coronavirus disease 2019 therapeutics, early in the pandemic the Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership rapidly designed a unique therapeutic agent intake and assessment process for candidate treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchman, Timothy G., Draghia-Akli, Ruxandra, Adam, Stacey J., Aggarwal, Neil R., Fessel, Joshua P., Higgs, Elizabeth S., Menetski, Joseph P., Read, Sarah W., Hughes, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507598/
https://www.ncbi.nlm.nih.gov/pubmed/34495876
http://dx.doi.org/10.1097/CCM.0000000000005295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507598/
https://www.ncbi.nlm.nih.gov/pubmed/34495876
http://dx.doi.org/10.1097/CCM.0000000000005295

Ejemplares similares